Table 1.
Variable | Value |
---|---|
Demographics | |
Age, y | 58.2 ± 14.4 |
Male sex | 91 (71.1%) |
Weight, kg | 84.2 ± 23.2 |
Height, cm | 169.1 ± 10.1 |
BMI. kg/m> | 29.6 ± 7.8 |
Comorbtdites | |
Hypertension | 67 (52.3%) |
Diabetes | 52 140.6%) |
CKD stages 1 –4 | 32 (25.0%) |
Kidney failure | 22 (16.6%) |
CHF | 43 (33.6%) |
Liver disease | 32 (25.0%) |
Cancer | 18 (14.1%) |
Main clinical diagnosis at CKRT initiation | |
Sepsis | 46 (36.9%) |
Shock other than sepsis | 43 (33.6%) |
Cardiovascular disease | 38 (29.7%) |
Urinary calculus | 1 (0.8%) |
Disease severity | |
SOFA score at dialysis start | 14.9 ± 3.3 |
Laboratory data at CKRT initiation | |
Serum urea nitrogen, mg/dL | 55.5 ± 41.3 |
Creatinine, mg/dL | 3.6 ± 2.5 |
pH | 7.3 ± 0.1 |
Patient outcomes | |
CKRT duration, d | 5.7 [2.9–12.5] |
Hospital length of stay, d | 27.0 [12.5–43.5] |
ICU length of stay, d | 13.0 [8.0–22.5] |
ICU mortality | 56 (42.9%) |
In-hospital mortality | 65 (50.8%) |
Values for continuous variables presented as mean ± SD or median [interquartile range]; categorical variables, as counts (percentage). Abbreviations: BMI, body mass index; CHF, congestive heart falure: CKO, chronic kidney disease; CKRT, continuous kidney replacement therapy; ICU, intensve care unit; SOFA, Sequential Organ Failure Assessment.